- Nachrichtendetail
-
17.06.2024 08:02:42 - dpa-AFX: *ASTRAZENECA SAYS IMFINZI PLUS CHEMOTHERAPY APPROVED IN THE US FOR ENDOMETRIAL CANCER
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
ASTRAZENECA PLC DL-,25 | 886455 | Xetra | 147,050 | 28.06.24 16:32:32 | +1,300 | +0,89% | 147,000 | 147,150 | 146,350 | 145,750 |
